© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
March 26, 2021
An expert physician in cardiology and metabolic management walks through a presentation on identifying, addressing, and continually treating for heightened cardiometabolic risk.
January 21, 2021
The association between genetic liability to smoking and ASCVD was independent from the effects of smoking on traditional cardiovascular risk factors.
June 23, 2020
While often referred to as "Good cholesterol" new research suggests HDL measurements do little for predicting risk of heart attack in Black patients
June 09, 2020
A new study from the University of Arizona is shedding light on the psychological impact of Tai Chi in patients with cardiovascular disease.
June 08, 2020
A new analysis examines impact of treatment adherence in more than 1.2 million patients.
June 01, 2020
The expanded indication is the first regulatory approval for aspirin plus ticagrelor dual antiplatelet therapy in those with a high risk, but no history of heart attack or stroke.
May 29, 2020
Discussing the results of a recent analysis that estimated the impact of comprehensive therapy with SGLT2 inhibitors, ARNIs, and MRAs in patients with HFrEF.
May 28, 2020
The latest scientific statement from the American Heart Association examines disparities in risk factors, social determinants of health, and management approaches for these patients.
May 21, 2020
A new analysis of the DASH trial found a fruit-and-vegetable diet was associated with lower levels of hs-cTnl and NT-proBNP.
May 16, 2020
A new analysis of 28 studies including more than 90k patients suggests 1-in-10 of these conditions is misdiagnosed, results in delays in treatment and potential harm.